BioNxt Solutions Inc
CNSX:BNXT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Temairazu Inc
TSE:2477
|
JP |
|
Kenko Mayonnaise Co Ltd
TSE:2915
|
JP |
|
G
|
GOGOX Holdings Ltd
HKEX:2246
|
CN |
BioNxt Solutions Inc
Total Equity
BioNxt Solutions Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioNxt Solutions Inc
CNSX:BNXT
|
Total Equity
-CA$7.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Total Equity
-$554m
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Total Equity
CA$758.2m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
19%
|
|
|
Cronos Group Inc
TSX:CRON
|
Total Equity
$1.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
63%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Total Equity
$130.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
46%
|
CAGR 10-Years
84%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Total Equity
CA$767.3m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
BioNxt Solutions Inc
Glance View
BioNxt Solutions, Inc. engages in the production, extraction and sale of medical cannabis. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-08-06. The firm is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The firm has research and development operations in North America and Europe, with an operational focus in Germany. The firm is also focused on regulatory approval and commercialization of medical products for European markets.
See Also
What is BioNxt Solutions Inc's Total Equity?
Total Equity
-7.9m
CAD
Based on the financial report for Dec 31, 2024, BioNxt Solutions Inc's Total Equity amounts to -7.9m CAD.
What is BioNxt Solutions Inc's Total Equity growth rate?
Total Equity CAGR 1Y
-49%
Over the last year, the Total Equity growth was -49%.
